“Now we know that we can use the epigenome of Epstein Barr Virus against the gastric cancer that it affects—that’s an exciting potential cancer therapy we have as a result of investigating the interplay between epigenetic patterns and disease lifecycle,” explained Tempera.
The Wistar Institute, West Philadelphia Skills Initiative, Iovance Biotherapeutics, PIDC, The Chamber of Commerce for Greater Philadelphia Launch Second Recruitment for the Award-Winning Program on August 22
PHILADELPHIA — (JULY 26, 2023) — It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its connection to lymphomas.
